{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:35:31Z","timestamp":1781613331174,"version":"3.54.5"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.xphs.2023.08.016","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T11:28:54Z","timestamp":1692617334000},"page":"669-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Combined Effect of Shaking Orbit and Vial Orientation on the Agitation-Induced Aggregation of Proteins"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-7827","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Dasnoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Illartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Queffelec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey","family":"Nkunku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Peerboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2023.08.016_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejpb.2018.07.011","article-title":"Parenteral protein formulations: an overview of approved products within the European Union","volume":"131","author":"Gervasi","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"10.1016\/j.xphs.2023.08.016_bib0002","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.xphs.2021.03.017","article-title":"A review of formulations of commercially available antibodies","volume":"110","author":"Strickley","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.08.016_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apcsb.2018.01.005","article-title":"Rational design of liquid formulations of proteins","volume":"112","author":"Manning","year":"2018","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.08.016_bib0004","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2018.08.043","article-title":"Protein aggregation - Mechanisms, detection, and control","volume":"550","author":"Wang","year":"2018","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.016_bib0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.xphs.2016.10.015","article-title":"Synergistic effect of cavitation and agitation on protein aggregation","volume":"106","author":"Torisu","year":"2017","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.016_bib0006","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.xphs.2019.10.015","article-title":"What makes polysorbate functional? Impact of polysorbate 80 grade and quality on IgG stability during mechanical stress","volume":"109","author":"Grabarek","year":"2020","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2023.08.016_bib0007","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/19420862.2017.1368602","article-title":"Forced degradation of recombinant monoclonal antibodies","volume":"9","author":"Nowak","year":"2017","journal-title":"MAbs"},{"issue":"6","key":"10.1016\/j.xphs.2023.08.016_bib0008","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/(SICI)1097-0290(19970620)54:6<503::AID-BIT1>3.0.CO;2-N","article-title":"Protein denaturation by combined effect of shear and air-liquid interface","volume":"54","author":"Maa","year":"1997","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.xphs.2023.08.016_bib0009","series-title":"Aggregation of Therapeutic Proteins","first-page":"301","article-title":"Protein aggregation and particle formation: effects of formulation, interfaces, and drug product manufacturing operations","author":"Mahler","year":"2010"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.016_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1208\/s12248-019-0312-3","article-title":"Interfacial stress in the development of biologics: fundamental understanding, current practice, and future perspective","volume":"21","author":"Li","year":"2019","journal-title":"AAPS J"},{"issue":"5","key":"10.1016\/j.xphs.2023.08.016_bib0011","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.xphs.2016.02.027","article-title":"Evaluating the role of the air-solution interface on the mechanism of subvisible particle formation caused by mechanical agitation for an IgG1 mAb","volume":"105","author":"Ghazvini","year":"2016","journal-title":"J Pharm Sci"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.08.016_bib0012","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2017.12.043","article-title":"Notorious but not understood: how liquid-air interfacial stress triggers protein aggregation","volume":"537","author":"Koepf","year":"2018","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.016_bib0013","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.xphs.2019.09.018","article-title":"An industry perspective on forced degradation studies of biopharmaceuticals: survey outcome and recommendations","volume":"109","author":"Halley","year":"2020","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.016_bib0014","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1208\/aapsj080359","article-title":"Effects of protein aggregates","volume":"8","author":"Rosenberg","year":"2006","journal-title":"AAPS J"},{"issue":"10","key":"10.1016\/j.xphs.2023.08.016_bib0015","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1002\/jps.21328","article-title":"Shaken, not stirred: mechanical stress testing of an IgG1 antibody","volume":"97","author":"Kiese","year":"2008","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.016_bib0016","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejpb.2009.11.005","article-title":"Relevant shaking stress conditions for antibody preformulation development","volume":"74","author":"Eppler","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.016_bib0017","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jps.22812","article-title":"Forced degradation of therapeutic proteins","volume":"101","author":"Hawe","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.08.016_bib0018","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejpb.2015.10.016","article-title":"Forced degradation studies of biopharmaceuticals","volume":"98","author":"Tamizi","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.016_bib0019","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.xphs.2016.11.021","article-title":"Shipping-induced aggregation in therapeutic antibodies: utilization of a scale-down model to assess degradation in monoclonal antibodies","volume":"106","author":"Fleischman","year":"2017","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.016_bib0020","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.xphs.2022.09.022","article-title":"Relationship between aggregation of therapeutic proteins and agitation parameters","volume":"112","author":"Kizuki","year":"2023","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.016_bib0021","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1208\/s12249-016-0540-0","article-title":"Visible and sub-visible particle formation for a model bioconjugate","volume":"18","author":"Lewis","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2023.08.016_bib0022","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejpb.2017.01.025","article-title":"Stabilizing two IgG1 monoclonal antibodies by surfactants","volume":"114","author":"Wang","year":"2017","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.016_bib0023","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijpharm.2011.11.044","article-title":"Computational fluid dynamics (CFD) insights into agitation stress methods in biopharmaceutical development","volume":"423","author":"Bai","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.08.016_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122321","article-title":"Understanding opalescence measurements of biologics - a comparison study of methods, standards, and molecules","volume":"628","author":"Kunz","year":"2022","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2023.08.016_bib0025","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1016\/j.xphs.2021.06.013","article-title":"Opalescence measurements: improvements in fundamental knowledge, identifying sources of analytical biases, and advanced applications for the development of therapeutic proteins","volume":"110","author":"Barros","year":"2021","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2023.08.016_bib0026","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11095-007-9516-9","article-title":"Extrinsic fluorescent dyes as tools for protein characterization","volume":"25","author":"Hawe","year":"2008","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.016_bib0027","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.xphs.2019.05.018","article-title":"Characterization of protein aggregates, silicone oil droplets, and protein-silicone interactions using imaging flow cytometry","volume":"109","author":"Probst","year":"2020","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.08.016_bib0028","series-title":"ISO 8362-1 - Injection Containers and Accessories \u2013 Part 1: Injection Vials Made of Glass Tubing","year":"2018"},{"key":"10.1016\/j.xphs.2023.08.016_bib0029","series-title":"ISO 8362-2 - Injection Containers and Accessories \u2013 Part 2: Closures for Injection Vials","year":"2015"},{"key":"10.1016\/j.xphs.2023.08.016_bib0030","series-title":"The Python Language Reference (v3.9)","year":"2020"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.016_bib0031","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s11095-010-0297-1","article-title":"Strategies for the assessment of protein aggregates in pharmaceutical biotech product development","volume":"28","author":"den Engelsman","year":"2011","journal-title":"Pharm Res"},{"issue":"21","key":"10.1016\/j.xphs.2023.08.016_bib0032","doi-asserted-by":"crossref","first-page":"9377","DOI":"10.1073\/pnas.88.21.9377","article-title":"Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces","volume":"88","author":"Sluzky","year":"1991","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.xphs.2023.08.016_bib0033","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/js980221r","article-title":"Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications","volume":"88","author":"Kerwin","year":"1999","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2023.08.016_bib0034","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/jps.21719","article-title":"Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution","volume":"98","author":"Thirumangalathu","year":"2009","journal-title":"J Pharm Sci"},{"issue":"11","key":"10.1016\/j.xphs.2023.08.016_bib0035","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1002\/jps.23299","article-title":"Mechanistic complexity of subvisible particle formation","volume":"101","author":"Simler","year":"2012","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.016_bib0036","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejpb.2014.01.004","article-title":"Agitation-induced aggregation and subvisible particulate formation in model proteins","volume":"87","author":"Jayaraman","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"10.1016\/j.xphs.2023.08.016_bib0037","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1021\/acs.molpharmaceut.5b00089","article-title":"Predicting the agitation-induced aggregation of monoclonal antibodies using surface tensiometry","volume":"12","author":"Shieh","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2023.08.016_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2022.05.002","article-title":"Identification of agitation-induced unfolding events causing aggregation of monoclonal antibodies using hydrogen exchange-mass spectrometry","author":"Gamage","year":"202211182210","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.016_bib0039","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1015108115452","article-title":"Inverse relationship of protein concentration and aggregation","volume":"19","author":"Treuheit","year":"2002","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.016_bib0040","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","article-title":"Dynamic light scattering: a practical guide and applications in biomedical sciences","volume":"8","author":"Stetefeld","year":"2016","journal-title":"Biophys Rev"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.016_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26020420","article-title":"Revisiting the Rate-Limiting Step of the ANS-Protein Binding at the Protein Surface and Inside the Hydrophobic Cavity","volume":"26","author":"Ota","year":"2021","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.xphs.2023.08.016_bib0042","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.xphs.2016.04.015","article-title":"Aggregation and particle formation of therapeutic proteins in contact with a novel fluoropolymer surface versus siliconized surfaces: effects of agitation in vials and in prefilled syringes","volume":"105","author":"Teska","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.08.016_bib0043","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejpb.2019.12.001","article-title":"Brij-58, a potential injectable protein-stabilizer used in therapeutic protein formulation","volume":"146","author":"Yue","year":"2020","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.016_bib0044","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/acs.molpharmaceut.8b00984","article-title":"Dynamic properties of novel excipient suggest mechanism for improved performance in liquid stabilization of protein biologics","volume":"16","author":"Katz","year":"2019","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.016_bib0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jps.2600630136","article-title":"CMC of polysorbates","volume":"63","author":"Wan","year":"1974","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.08.016_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121706","article-title":"Poloxamer 188 as surfactant in biological formulations - an alternative for polysorbate 20\/80?","volume":"620","author":"Bollenbach","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2023.08.016_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112320","article-title":"CMC determination using isothermal titration calorimetry for five industrially significant non-ionic surfactants","volume":"211","author":"Smith","year":"2022","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"7","key":"10.1016\/j.xphs.2023.08.016_bib0048","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1023\/A:1018994102218","article-title":"Techniques for assessing the effects of pharmaceutical excipients on the aggregation of porcine growth hormone","volume":"10","author":"Charman","year":"1993","journal-title":"Pharm Res"},{"issue":"12","key":"10.1016\/j.xphs.2023.08.016_bib0049","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1021\/js980175v","article-title":"Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions","volume":"87","author":"Bam","year":"1998","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2023.08.016_bib0050","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1021\/js980126i","article-title":"Effect of Tween 20 on freeze-thawing- and agitation-induced aggregation of recombinant human factor XIII","volume":"87","author":"Kreilgaard","year":"1998","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2023.08.016_bib0051","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jps.20365","article-title":"Effects of Tween 20 and Tween 80 on the stability of albutropin during agitation","volume":"94","author":"Chou","year":"2005","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2023.08.016_bib0052","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1002\/jps.21776","article-title":"Surface activity of a monoclonal antibody","volume":"98","author":"Mahler","year":"2009","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.016_bib0053","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/jps.21868","article-title":"Characterization of antibody aggregation: role of buried, unpaired cysteines in particle formation","volume":"99","author":"Brych","year":"2010","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.08.016_bib0054","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s11095-011-0385-x","article-title":"The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics","volume":"28","author":"Kishore","year":"2011","journal-title":"Pharm Res."},{"issue":"3","key":"10.1016\/j.xphs.2023.08.016_bib0055","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/jps.23434","article-title":"IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers","volume":"102","author":"Basu","year":"2013","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.016_bib0056","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1208\/s12249-017-0845-7","article-title":"Effect of surfactants on mechanical, thermal, and photostability of a monoclonal antibody","volume":"19","author":"Agarkhed","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.xphs.2023.08.016_bib0057","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.xphs.2019.01.029","article-title":"Conjugation of emtansine onto trastuzumab promotes aggregation of the antibody-drug conjugate by reducing repulsive electrostatic interactions and increasing hydrophobic interactions","volume":"108","author":"Gandhi","year":"2019","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.016_bib0058","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11095-021-03021-z","article-title":"A comprehensive assessment of all-oleate polysorbate 80: free fatty acid particle formation, interfacial protection and oxidative degradation","volume":"38","author":"Doshi","year":"2021","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2023.08.016_bib0059","unstructured":"Heitz M., Khan T., Kientz H.S., M\u00fcller C., Pfaff J.M. 2021. Alternative surfactants as stabilizers for therapeutic formulations. WO2022008468A1."},{"issue":"5","key":"10.1016\/j.xphs.2023.08.016_bib0060","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.xphs.2021.09.027","article-title":"Miniaturized forced degradation of therapeutic proteins and ADCs by agitation-induced aggregation using orbital shaking of microplates","volume":"111","author":"Johann","year":"2022","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.08.016_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2023.06.004","article-title":"Comparison of the protective effect of polysorbates, poloxamer and brij on antibody stability against different interfaces","author":"Z\u00fcrcher","year":"2023","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2023.08.016_bib0062","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jps.2600840609","article-title":"Effect of surfactants on the physical stability of recombinant human growth hormone","volume":"84","author":"Katakam","year":"1995","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.016_bib0063","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpb.2004.12.004","article-title":"Induction and analysis of aggregates in a liquid IgG1-antibody formulation","volume":"59","author":"Mahler","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.08.016_bib0064","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijpharm.2007.06.042","article-title":"Dual effects of Tween 80 on protein stability","volume":"347","author":"Wang","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.016_bib0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.xphs.2019.10.069","article-title":"Comparison of polysorbate 80 hydrolysis and oxidation on the aggregation of a monoclonal antibody","volume":"109","author":"Larson","year":"2020","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2023.08.016_bib0066","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1016\/j.xphs.2022.09.004","article-title":"Exploring the protein stabilizing capability of surfactants against agitation stress and the underlying mechanisms","volume":"111","author":"Zoeller","year":"2022","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2023.08.016_bib0067","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s11095-011-0393-x","article-title":"High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface","volume":"28","author":"Dasnoy","year":"2011","journal-title":"Pharm Res"},{"issue":"8","key":"10.1016\/j.xphs.2023.08.016_bib0068","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.xphs.2020.03.010","article-title":"Protein-polydimethylsiloxane particles in liquid vial monoclonal antibody formulations containing poloxamer 188","volume":"109","author":"Grapentin","year":"2020","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.016_bib0069","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10837459709022619","article-title":"Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses","volume":"2","author":"Katakam","year":"1997","journal-title":"Pharm Dev Technol"},{"issue":"29","key":"10.1016\/j.xphs.2023.08.016_bib0070","doi-asserted-by":"crossref","first-page":"34540","DOI":"10.1021\/acsami.3c05610","article-title":"Not the usual suspects: alternative surfactants for biopharmaceuticals","volume":"15","author":"Brosig","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"issue":"12","key":"10.1016\/j.xphs.2023.08.016_bib0071","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s11095-004-7691-5","article-title":"Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone","volume":"21","author":"Tavornvipas","year":"2004","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.016_bib0072","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/jps.21931","article-title":"Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin","volume":"99","author":"Serno","year":"2010","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.016_bib0073","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ejpb.2010.08.012","article-title":"Synthesis, characterization and assessment of suitability of trehalose fatty acid esters as alternatives for polysorbates in protein formulation","volume":"76","author":"Schiefelbein","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2023.08.016_bib0074","unstructured":"Food and Drugs Administration (FDA). Inactive Ingredients Database. Accessed on 21 July 2023. https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/inactive-ingredients-database-download."},{"issue":"7","key":"10.1016\/j.xphs.2023.08.016_bib0075","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.xphs.2021.02.029","article-title":"Machine learning and accelerated stress approaches to differentiate potential causes of aggregation in polyclonal antibody formulations during shipping","volume":"110","author":"Witeof","year":"2021","journal-title":"J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2023.08.016_bib0076","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jps.23150","article-title":"Accelerated stability studies of abatacept formulations: comparison of freeze-thawing- and agitation-induced stresses","volume":"101","author":"Cordes","year":"2012","journal-title":"J Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2023.08.016_bib0077","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1002\/jps.23225","article-title":"Particles shed from syringe filters and their effects on agitation-induced protein aggregation","volume":"101","author":"Liu","year":"2012","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.016_bib0078","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jps.21858","article-title":"Equilibrium studies of protein aggregates and homogeneous nucleation in protein formulation","volume":"99","author":"Kiese","year":"2010","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2023.08.016_bib0079","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1002\/jps.23738","article-title":"Radar chart array analysis to visualize effects of formulation variables on IgG1 particle formation as measured by multiple analytical techniques","volume":"102","author":"Kalonia","year":"2013","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2023.08.016_bib0080","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11095-008-9792-z","article-title":"Effect of ions on agitation- and temperature-induced aggregation reactions of antibodies","volume":"26","author":"Fesinmeyer","year":"2009","journal-title":"Pharm Res"},{"issue":"28","key":"10.1016\/j.xphs.2023.08.016_bib0081","doi-asserted-by":"crossref","first-page":"25118","DOI":"10.1074\/jbc.M110.160457","article-title":"Classification and characterization of therapeutic antibody aggregates","volume":"286","author":"Joubert","year":"2011","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.xphs.2023.08.016_bib0082","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1815995","article-title":"An accelerated surface-mediated stress assay of antibody instability for developability studies","volume":"12","author":"Kopp","year":"2020","journal-title":"MAbs"},{"issue":"7","key":"10.1016\/j.xphs.2023.08.016_bib0083","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.xphs.2022.03.002","article-title":"Freeze-dried monoclonal antibody formulations are unexpectedly more prone to degradation than liquid formulations under shaking stress","volume":"111","author":"Fang","year":"2022","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.08.016_bib0084","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jps.23839","article-title":"Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions","volume":"103","author":"Telikepalli","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.08.016_bib0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2018.04.024","article-title":"The missing piece in the puzzle: prediction of aggregation via the protein-protein interaction parameter A(\u2217)(2)","volume":"128","author":"Koepf","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"10.1016\/j.xphs.2023.08.016_bib0086","first-page":"399","article-title":"Effects of nonionic surfactants on the physical stability of immunoglobulin G in aqueous solution during mechanical agitation","volume":"58","author":"Vidanovic","year":"2003","journal-title":"Pharmazie"},{"issue":"20","key":"10.1016\/j.xphs.2023.08.016_bib0087","doi-asserted-by":"crossref","first-page":"12539","DOI":"10.1021\/la202125c","article-title":"Mechanical stress affects glucagon fibrillation kinetics and fibril structure","volume":"27","author":"Macchi","year":"2011","journal-title":"Langmuir"},{"issue":"2","key":"10.1016\/j.xphs.2023.08.016_bib0088","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/jps.23408","article-title":"Ionic strength affects tertiary structure and aggregation propensity of a monoclonal antibody adsorbed to silicone oil-water interfaces","volume":"102","author":"Gerhardt","year":"2013","journal-title":"J Pharm Sci"},{"issue":"12","key":"10.1016\/j.xphs.2023.08.016_bib0089","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1023\/A:1013334916162","article-title":"In situ study of insulin aggregation induced by water-organic solvent interface","volume":"18","author":"Kwon","year":"2001","journal-title":"Pharm Res"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923003349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923003349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:44:47Z","timestamp":1758361487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923003349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0022354923003349"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.08.016","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Effect of Shaking Orbit and Vial Orientation on the Agitation-Induced Aggregation of Proteins","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}